Epidemiological analysis of patients with type 2 diabetes in France

Journal of Diabetes and its Complications

Volumn 14, Issue 5, 2000, Pages 242-249

  Grimaldi, A ^a   Grange V ^b   Allannic, H ^c   Passa, P ^d   Rodier, M ^e   Cornet, P ^f   Duprat, I ^b   Duc Dodon, P ^f   Lemaire, A ^f   Liard, F ^f   Eschwege E ^g  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b Bayer Pharma   (France)

^c RENNES UNIVERSITY HOSPITAL   (France)

^d SAINT LOUIS HOSPITAL   (France)

^e DEPARTMENT OF NEUROLOGY   (France)

^f National Institute for Health and Medical Research U 258 ^*  (France)

^g INSERM   (France)

Author keywords

Complications; Epidemiological data; Type 2 diabetes

Indexed keywords

ACARBOSE; BIGUANIDE DERIVATIVE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA DERIVATIVE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES CONTROL; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE DURATION; DRUG INDICATION; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FRANCE; GENERAL PRACTITIONER; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

ACARBOSE; ADULT; AGED; DATABASES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; FAMILY PRACTICE; FEMALE; FRANCE; HEART DISEASES; HUMANS; HYPOGLYCEMIC AGENTS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED;

EID: 0033663743     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8727(00)00120-3     Document Type: Article

References (18)

1. The rising global burden of diabetes and its complications: Estimates and projections to the year 2010
2. La population diabetique en France. Resultats d'une etude portant sur un panel representatif
3. Management of type 2 diabetes mellitus in France: Attitudes and practices among a representative sample of general practitioners
4. Reductions of glycosylated haemoglobin and postprandial hyperglycaemia by acarbose in patients with NIDDM
5. Low prevalence of long term complications in non insulin dependent diabetes mellitus in France: A multicenter study
6. Epidemiologie, prise en charge et cout du diabete de type 2 en France en 1998
7. Prevalence des 30 affections de longue duree pour les affilies au regime general de l'assurance maladie en 1994
8. Efficacy of 24 week monotherapy with acarbose, gliblenclamide or placebo in NIDDM patients: The Essen study
9. Efficacy of 24 week monotherapy with acarbose, metformin or placebo in dietary treated NIDDM patients: The Essen II study
10. Long term effect of acarbose on glycaemic control in non-insulin-dependent mellitus: A placebo-controlled double-blind study
11. Efficacy and safety of acarbose in the treatment of type II diabetes: Data from a 2 year surveillance study
12. Prevalence of non-insulin dependent diabetes as perceived by general practitioners in France
13. Les echecs des traitements par antidiabetiques oraux
14. Pattern of treatment among diabetic patients in France
15. Drugs on the horizon for the treatment of type II diabetes
16. Managing the burden of type 2 diabetes: An international survey of physicians
17. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)